• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LIFECELL ARTIA RECONSTRUCTIVE TISSUE MATRIX, CONTOUR LARGE; MESH, SURGICAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LIFECELL ARTIA RECONSTRUCTIVE TISSUE MATRIX, CONTOUR LARGE; MESH, SURGICAL Back to Search Results
Catalog Number CL1097
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Erythema (1840); Unspecified Infection (1930); Seroma (2069)
Event Date 09/15/2018
Event Type  Injury  
Manufacturer Narrative
Conclusion: this event is being reported for the medical intervention to treat the late onset infected seroma.The report of patchy areas of incorporation at the time of exchange is an incidental finding.The device remains implanted and has not been returned for evaluation.Based on limited information, including no identification of the relevant lot number, a relationship between the event and the artia could not be determined.Due to lack of information, artia as a contributing factor cannot be ruled out.Multiple attempts to obtain additional information are being made, including the identification of the lot number.To date, the lot number associated with this event remains unknown; therefore an internal investigation into the device history records could not be performed.Should additional information be reported, a follow up adverse event report will be submitted.No further actions are required as a nonconformance could not be confirmed.
 
Event Description
It was reported that a patient underwent a right side pre-pectoral unilateral reconstruction with two artia devices on (b)(6) 2017.On (b)(6) 2017, patient underwent exchange where the artia was noted intra-op to have areas of patchy incorporation.On (b)(6) 2018, patient underwent a right nipple-areola reconstruction.The following month on (b)(6) 2018, patient developed red breast and a late onset infected seroma.Patient was placed on antibiotics and drain placed for 4 weeks and seroma resolved.Cultures of seroma fluid were negative.Patient is currently ok.The artia devices are still in place.This complaint is associated with the first of 2 devices implanted on the right side in this patient.Refer to medwatch 1000306051-2018-00158 for the second device implanted in this patient.
 
Event Description
This is a follow up #1 to report updated information received on 04/jan/2019 and 07/jan/2019.The patient underwent a sub-pectoral reconstruction with one artia device, lot up100105-01.As reported in the initial: it was reported that a patient underwent a right side pre-pectoral unilateral reconstruction with two artia devices on (b)(6) 2017.On (b)(6) 2017, patient underwent exchange where the artia was noted intra-op to have areas of patchy incorporation.On (b)(6) 2018, patient underwent a right nipple-areola reconstruction.The following month on (b)(6) 2018, patient developed red breast and a late onset infected seroma.Patient was placed on antibiotics and drain placed for 4 weeks and seroma resolved.Cultures of seroma fluid were negative.Patient is currently ok.The artia devices are still in place.This complaint is associated with the first of 2 devices implanted on the right side in this patient.Refer to medwatch 1000306051-2018-00158 for the second device implanted in this patient.
 
Manufacturer Narrative
Qa investigation into lot up100105 resulted in no remarkable findings including 38 devices distributed with no similar complaints against the lot and no related deviations or nonconformances revealed during processing.Lot up100105 was terminally sterilized within the process parameters and met all qc release criteria.Based on the results of the investigation, a relationship between the artia and this event could not be determined.It should be noted that the artia device remains implanted.No further actions are required at this time, as a nonconformance could not be confirmed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARTIA RECONSTRUCTIVE TISSUE MATRIX, CONTOUR LARGE
Type of Device
MESH, SURGICAL
Manufacturer (Section D)
LIFECELL
1 millennium way
branchburg NJ 08876
MDR Report Key8217747
MDR Text Key132091096
Report Number1000306051-2018-00156
Device Sequence Number1
Product Code FTM
Combination Product (y/n)N
PMA/PMN Number
K142326
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup
Report Date 01/30/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/04/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/31/2019
Device Catalogue NumberCL1097
Device Lot NumberUP100105
Was Device Available for Evaluation? No
Date Manufacturer Received01/04/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
NO INFORMATION; NO INFORMATION; NO INFORMATION
Patient Outcome(s) Required Intervention;
-
-